MedPath

Treatment of Great Saphenous Vein Varicosities

Not Applicable
Completed
Conditions
Varicose Veins
Interventions
Procedure: Endovenous chemical ablation with Trendelenburg's operation (eCAT)
Registration Number
NCT05655416
Lead Sponsor
Al-Azhar University
Brief Summary

Venous insufficiency at lower extremities may result in clinical problems from cosmetic issues to ulcerations. When the frequency of venous insufficiency and its related problems are considered besides their diversity, it is encountered as a public health issue. This pathology is reported to affect 40% of women and 20% of men.1 Patients with varicose veins may complain of unsightly appearance, aching, heaviness, pruritus, and early fatigue of the affected leg. These symptoms worsen with prolonged standing and sitting and are relieved by elevation of the leg above the level of the heart. Also, mild edema is often present. More severe signs include thrombophlebitis, hyperpigmentation, lipodermatosclerosis, ulceration, and bleeding

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
55
Inclusion Criteria
  • Patients presented by primary VV of the LL complaining of Leg pain cosmetic disfigurement, leg ulcer, itching, or pigmentation at LL
  • the incompetence of the saphenofemoral junction (SFJ) and or saphenopopliteal junction (SPJ).
Exclusion Criteria
  • Lower limb involvement by any of the following conditions; secondary VV, recurrent VV, lymphedema, acute superficial thrombophlebitis, arterio-venous fistula (congenital or acquired), congenital anomalies of the venous system, general comorbidities, skin infection or ischemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Lower limb varicose veinEndovenous chemical ablation with Trendelenburg's operation (eCAT)-
Primary Outcome Measures
NameTimeMethod
GSV Patencyat one year post operative

Great saphenous Vein Patency: is a categorical outcome that will be assesd by dopler ultrasound. it may be patent or partilly occluded or completely occluded or recanalized.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Walied Khereba

🇪🇬

Zagazig, Egypt

© Copyright 2025. All Rights Reserved by MedPath